HEAL.JK PT Medikaloka Hermina Tbk
Company Analysis
Latest News
π’ HEAL.JK is trading 9% up today on no clear catalyst
HEAL.JK is trading 9% up today at approximately IDR880β895 on no clear catalyst, rebounding strongly from its previous close of IDR810. β’ The share price is...
π’ HEAL.JK makes sharp 10.5% jump
HEAL.JK is trading at $895.00, up 10.5% versus the comparison close of $810.00 during regular trading. This is a price-movement alert; no separate...
π’ HEAL.JK is trading 8.7% up today after technical recovery from oversold levels
HEAL.JK is trading 8.7% up at IDR 875 today, staging a sharp technical recovery from recent oversold levels. β’ The rebound follows a drop to IDR 810 that...
π’ HEAL.JK is trading 9.3% up today on technical recovery from oversold levels
HEAL.JK is trading 9.3% up today at IDR 880 as the stock stages a technical recovery from oversold levels. β’ The rebound follows a recent drop to IDR 810 that...
π’ HEAL.JK is trading 8.1% up today on technical recovery from oversold levels
HEAL.JK is trading 8.1% up today at IDR 870, staging a recovery following recent market-driven weakness. β’ The stock bounced from a low of IDR 810 reached on...
π’ HEAL.JK is trading 6.2% up today after rebounding from a sharp selloff
HEAL.JK is trading 6.2% up today at IDR 855, staging a technical rebound following a period of market-driven pressure. β’ The recovery follows a drop to IDR...
π’ HEAL.JK is trading 6.8% up today after a technical rebound from the prior session's selloff
HEAL.JK is trading at $860.00 (+6.83%) following a technical rebound from the prior sessionβs sharp selloff. β’ The move follows a volatile session on June 24...
π’ HEAL.JK is trading 1% up today in a technical rebound after sharp losses
HEAL.JK is trading 1% up at IDR 810, staging a modest recovery following a significant decline in the previous session. β’ No fresh company-specific news,...
π’ PT Medikaloka Hermina Tbk is trading 5% up today amid a sharp two-day rebound
PT Medikaloka Hermina Tbk is trading 5% up today at $915 following a sharp two-day rebound that appears to be unexplained by company-specific news. β’ The...